nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Lomustine—brain cancer	0.22	0.303	CbGbCtD
Ciclesonide—CYP2D6—Hydroxyurea—brain cancer	0.167	0.23	CbGbCtD
Ciclesonide—CYP3A4—Temozolomide—brain cancer	0.165	0.227	CbGbCtD
Ciclesonide—CYP3A4—Lomustine—brain cancer	0.14	0.193	CbGbCtD
Ciclesonide—CYP3A4—Etoposide—brain cancer	0.0338	0.0466	CbGbCtD
Ciclesonide—Type IV hypersensitivity reaction—Procarbazine—brain cancer	0.0287	0.13	CcSEcCtD
Ciclesonide—Hyperadrenocorticism—Temozolomide—brain cancer	0.0141	0.0638	CcSEcCtD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON1—brain cancer	0.0101	0.32	CbGpPWpGaD
Ciclesonide—Hoarseness—Procarbazine—brain cancer	0.0082	0.0371	CcSEcCtD
Ciclesonide—Fluocinonide—SMO—brain cancer	0.00681	1	CrCbGaD
Ciclesonide—Contusion—Lomustine—brain cancer	0.00651	0.0295	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Lomustine—brain cancer	0.00624	0.0283	CcSEcCtD
Ciclesonide—Impaired healing—Carmustine—brain cancer	0.00522	0.0236	CcSEcCtD
Ciclesonide—Dysphonia—Procarbazine—brain cancer	0.00438	0.0199	CcSEcCtD
Ciclesonide—Oral candidiasis—Carmustine—brain cancer	0.00355	0.0161	CcSEcCtD
Ciclesonide—Oral candidiasis—Temozolomide—brain cancer	0.00343	0.0155	CcSEcCtD
Ciclesonide—Ulcer—Hydroxyurea—brain cancer	0.00295	0.0134	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—HIC1—brain cancer	0.00293	0.0927	CbGpPWpGaD
Ciclesonide—Haemoglobin—Lomustine—brain cancer	0.00287	0.013	CcSEcCtD
Ciclesonide—Haemorrhage—Lomustine—brain cancer	0.00285	0.0129	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00265	0.012	CcSEcCtD
Ciclesonide—Infection—Carboplatin—brain cancer	0.0023	0.0104	CcSEcCtD
Ciclesonide—Candida infection—Carmustine—brain cancer	0.00215	0.00975	CcSEcCtD
Ciclesonide—Candida infection—Temozolomide—brain cancer	0.00208	0.00943	CcSEcCtD
Ciclesonide—SERPINA6—hindbrain—brain cancer	0.00204	0.129	CbGeAlD
Ciclesonide—Pneumonia—Procarbazine—brain cancer	0.00203	0.00919	CcSEcCtD
Ciclesonide—Infection—Lomustine—brain cancer	0.00201	0.00912	CcSEcCtD
Ciclesonide—Chest discomfort—Etoposide—brain cancer	0.00197	0.00893	CcSEcCtD
Ciclesonide—Face oedema—Hydroxyurea—brain cancer	0.00196	0.00886	CcSEcCtD
Ciclesonide—Epistaxis—Procarbazine—brain cancer	0.0019	0.00862	CcSEcCtD
Ciclesonide—Diabetes mellitus—Carmustine—brain cancer	0.00188	0.00853	CcSEcCtD
Ciclesonide—Swelling—Carmustine—brain cancer	0.00186	0.00841	CcSEcCtD
Ciclesonide—Ear pain—Temozolomide—brain cancer	0.00185	0.0084	CcSEcCtD
Ciclesonide—Ulcer—Etoposide—brain cancer	0.00184	0.00835	CcSEcCtD
Ciclesonide—Haemoglobin—Procarbazine—brain cancer	0.00182	0.00824	CcSEcCtD
Ciclesonide—Haemorrhage—Procarbazine—brain cancer	0.00181	0.0082	CcSEcCtD
Ciclesonide—Gastroenteritis—Temozolomide—brain cancer	0.00179	0.00809	CcSEcCtD
Ciclesonide—Nasal congestion—Temozolomide—brain cancer	0.00174	0.00787	CcSEcCtD
Ciclesonide—CES1—Irinotecan Pathway—APC—brain cancer	0.00167	0.0529	CbGpPWpGaD
Ciclesonide—Candida infection—Etoposide—brain cancer	0.00167	0.00754	CcSEcCtD
Ciclesonide—Weight increased—Hydroxyurea—brain cancer	0.00159	0.00722	CcSEcCtD
Ciclesonide—Face oedema—Carmustine—brain cancer	0.00158	0.00716	CcSEcCtD
Ciclesonide—Infestation NOS—Hydroxyurea—brain cancer	0.00156	0.00707	CcSEcCtD
Ciclesonide—Infestation—Hydroxyurea—brain cancer	0.00156	0.00707	CcSEcCtD
Ciclesonide—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00154	0.0488	CbGpPWpGaD
Ciclesonide—Face oedema—Temozolomide—brain cancer	0.00153	0.00692	CcSEcCtD
Ciclesonide—Swelling—Etoposide—brain cancer	0.00144	0.0065	CcSEcCtD
Ciclesonide—Haemoglobin—Hydroxyurea—brain cancer	0.00141	0.00638	CcSEcCtD
Ciclesonide—Haemorrhage—Hydroxyurea—brain cancer	0.0014	0.00635	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Temozolomide—brain cancer	0.0014	0.00632	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00139	0.0439	CbGpPWpGaD
Ciclesonide—Cough—Procarbazine—brain cancer	0.00138	0.00623	CcSEcCtD
Ciclesonide—Hypertension—Procarbazine—brain cancer	0.00136	0.00616	CcSEcCtD
Ciclesonide—Arthralgia—Procarbazine—brain cancer	0.00134	0.00608	CcSEcCtD
Ciclesonide—Bronchitis—Temozolomide—brain cancer	0.00132	0.00596	CcSEcCtD
Ciclesonide—Dry mouth—Procarbazine—brain cancer	0.00131	0.00594	CcSEcCtD
Ciclesonide—Infection—Procarbazine—brain cancer	0.00128	0.00579	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Temozolomide—brain cancer	0.00127	0.00576	CcSEcCtD
Ciclesonide—Pneumonia—Carmustine—brain cancer	0.00127	0.00575	CcSEcCtD
Ciclesonide—Weight increased—Temozolomide—brain cancer	0.00124	0.00564	CcSEcCtD
Ciclesonide—Urinary tract infection—Carmustine—brain cancer	0.00123	0.00556	CcSEcCtD
Ciclesonide—Pneumonia—Temozolomide—brain cancer	0.00123	0.00556	CcSEcCtD
Ciclesonide—Infestation NOS—Temozolomide—brain cancer	0.00122	0.00552	CcSEcCtD
Ciclesonide—Infestation—Temozolomide—brain cancer	0.00122	0.00552	CcSEcCtD
Ciclesonide—Nausea—Lomustine—brain cancer	0.0012	0.00545	CcSEcCtD
Ciclesonide—Urinary tract infection—Temozolomide—brain cancer	0.00119	0.00537	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00117	0.00531	CcSEcCtD
Ciclesonide—Sinusitis—Temozolomide—brain cancer	0.00114	0.00518	CcSEcCtD
Ciclesonide—Haemoglobin—Carmustine—brain cancer	0.00114	0.00516	CcSEcCtD
Ciclesonide—Haemorrhage—Carmustine—brain cancer	0.00113	0.00513	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Etoposide—brain cancer	0.00112	0.00506	CcSEcCtD
Ciclesonide—Fatigue—Procarbazine—brain cancer	0.00111	0.00502	CcSEcCtD
Ciclesonide—Haemoglobin—Temozolomide—brain cancer	0.0011	0.00498	CcSEcCtD
Ciclesonide—Haemorrhage—Temozolomide—brain cancer	0.00109	0.00496	CcSEcCtD
Ciclesonide—Pharyngitis—Temozolomide—brain cancer	0.00109	0.00492	CcSEcCtD
Ciclesonide—Bronchospasm—Etoposide—brain cancer	0.00108	0.00488	CcSEcCtD
Ciclesonide—Urticaria—Procarbazine—brain cancer	0.00102	0.00463	CcSEcCtD
Ciclesonide—Infection—Hydroxyurea—brain cancer	0.000989	0.00448	CcSEcCtD
Ciclesonide—Immune system disorder—Temozolomide—brain cancer	0.000989	0.00448	CcSEcCtD
Ciclesonide—Mediastinal disorder—Temozolomide—brain cancer	0.000986	0.00447	CcSEcCtD
Ciclesonide—Pneumonia—Etoposide—brain cancer	0.000981	0.00445	CcSEcCtD
Ciclesonide—Infestation—Etoposide—brain cancer	0.000976	0.00442	CcSEcCtD
Ciclesonide—Infestation NOS—Etoposide—brain cancer	0.000976	0.00442	CcSEcCtD
Ciclesonide—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000956	0.0303	CbGpPWpGaD
Ciclesonide—Back pain—Carmustine—brain cancer	0.000954	0.00432	CcSEcCtD
Ciclesonide—Dysgeusia—Temozolomide—brain cancer	0.000933	0.00423	CcSEcCtD
Ciclesonide—Asthenia—Procarbazine—brain cancer	0.000923	0.00418	CcSEcCtD
Ciclesonide—Back pain—Temozolomide—brain cancer	0.000922	0.00418	CcSEcCtD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00092	0.0291	CbGpPWpGaD
Ciclesonide—NR3C1—hindbrain—brain cancer	0.000894	0.0564	CbGeAlD
Ciclesonide—Dyspnoea—Hydroxyurea—brain cancer	0.000887	0.00402	CcSEcCtD
Ciclesonide—Dyspepsia—Hydroxyurea—brain cancer	0.000876	0.00397	CcSEcCtD
Ciclesonide—Angioedema—Temozolomide—brain cancer	0.000871	0.00394	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000859	0.00389	CcSEcCtD
Ciclesonide—Fatigue—Hydroxyurea—brain cancer	0.000858	0.00389	CcSEcCtD
Ciclesonide—Hypertension—Carmustine—brain cancer	0.000851	0.00386	CcSEcCtD
Ciclesonide—Dizziness—Procarbazine—brain cancer	0.000851	0.00385	CcSEcCtD
Ciclesonide—SERPINA6—pituitary gland—brain cancer	0.000845	0.0534	CbGeAlD
Ciclesonide—Palpitations—Temozolomide—brain cancer	0.000842	0.00381	CcSEcCtD
Ciclesonide—Chest pain—Carmustine—brain cancer	0.000839	0.0038	CcSEcCtD
Ciclesonide—Cough—Temozolomide—brain cancer	0.000831	0.00377	CcSEcCtD
Ciclesonide—Hypertension—Temozolomide—brain cancer	0.000823	0.00373	CcSEcCtD
Ciclesonide—Arthralgia—Temozolomide—brain cancer	0.000811	0.00367	CcSEcCtD
Ciclesonide—Rash—Procarbazine—brain cancer	0.000811	0.00367	CcSEcCtD
Ciclesonide—Dermatitis—Procarbazine—brain cancer	0.00081	0.00367	CcSEcCtD
Ciclesonide—Headache—Procarbazine—brain cancer	0.000806	0.00365	CcSEcCtD
Ciclesonide—Infection—Carmustine—brain cancer	0.000799	0.00362	CcSEcCtD
Ciclesonide—Dry mouth—Temozolomide—brain cancer	0.000793	0.00359	CcSEcCtD
Ciclesonide—Immune system disorder—Etoposide—brain cancer	0.000791	0.00358	CcSEcCtD
Ciclesonide—Mediastinal disorder—Etoposide—brain cancer	0.000789	0.00358	CcSEcCtD
Ciclesonide—Infection—Temozolomide—brain cancer	0.000773	0.0035	CcSEcCtD
Ciclesonide—Nausea—Procarbazine—brain cancer	0.000764	0.00346	CcSEcCtD
Ciclesonide—Dysgeusia—Etoposide—brain cancer	0.000747	0.00338	CcSEcCtD
Ciclesonide—Back pain—Etoposide—brain cancer	0.000738	0.00334	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000733	0.00332	CcSEcCtD
Ciclesonide—Dyspnoea—Carmustine—brain cancer	0.000717	0.00325	CcSEcCtD
Ciclesonide—Asthenia—Hydroxyurea—brain cancer	0.000714	0.00324	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000709	0.00321	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Carmustine—brain cancer	0.000695	0.00315	CcSEcCtD
Ciclesonide—Dyspnoea—Temozolomide—brain cancer	0.000693	0.00314	CcSEcCtD
Ciclesonide—Dyspepsia—Temozolomide—brain cancer	0.000685	0.0031	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000671	0.00304	CcSEcCtD
Ciclesonide—Fatigue—Temozolomide—brain cancer	0.00067	0.00304	CcSEcCtD
Ciclesonide—CYP2D6—hindbrain—brain cancer	0.000665	0.042	CbGeAlD
Ciclesonide—Cough—Etoposide—brain cancer	0.000665	0.00301	CcSEcCtD
Ciclesonide—Hypertension—Etoposide—brain cancer	0.000658	0.00298	CcSEcCtD
Ciclesonide—Dizziness—Hydroxyurea—brain cancer	0.000658	0.00298	CcSEcCtD
Ciclesonide—CES1—endocrine gland—brain cancer	0.000656	0.0414	CbGeAlD
Ciclesonide—SERPINA6—endocrine gland—brain cancer	0.000655	0.0413	CbGeAlD
Ciclesonide—Chest pain—Etoposide—brain cancer	0.000649	0.00294	CcSEcCtD
Ciclesonide—CES1—head—brain cancer	0.000647	0.0409	CbGeAlD
Ciclesonide—SERPINA6—head—brain cancer	0.000647	0.0408	CbGeAlD
Ciclesonide—Rash—Hydroxyurea—brain cancer	0.000628	0.00284	CcSEcCtD
Ciclesonide—Dermatitis—Hydroxyurea—brain cancer	0.000627	0.00284	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—SIRT1—brain cancer	0.000627	0.0198	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000625	0.0198	CbGpPWpGaD
Ciclesonide—Headache—Hydroxyurea—brain cancer	0.000624	0.00282	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CCNE1—brain cancer	0.000619	0.0196	CbGpPWpGaD
Ciclesonide—Infection—Etoposide—brain cancer	0.000618	0.0028	CcSEcCtD
Ciclesonide—Urticaria—Temozolomide—brain cancer	0.000618	0.0028	CcSEcCtD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000601	0.019	CbGpPWpGaD
Ciclesonide—Nausea—Hydroxyurea—brain cancer	0.000591	0.00268	CcSEcCtD
Ciclesonide—CES1—central nervous system—brain cancer	0.000591	0.0373	CbGeAlD
Ciclesonide—SERPINA6—central nervous system—brain cancer	0.00059	0.0373	CbGeAlD
Ciclesonide—Asthenia—Carmustine—brain cancer	0.000577	0.00262	CcSEcCtD
Ciclesonide—SERPINA6—cerebellum—brain cancer	0.000577	0.0364	CbGeAlD
Ciclesonide—Asthenia—Temozolomide—brain cancer	0.000558	0.00253	CcSEcCtD
Ciclesonide—Dyspnoea—Etoposide—brain cancer	0.000555	0.00251	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Etoposide—brain cancer	0.000537	0.00243	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—brain cancer	0.000537	0.00243	CcSEcCtD
Ciclesonide—Dizziness—Carmustine—brain cancer	0.000532	0.00241	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000525	0.0166	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.000523	0.0165	CbGpPWpGaD
Ciclesonide—Dizziness—Temozolomide—brain cancer	0.000514	0.00233	CcSEcCtD
Ciclesonide—NR3C1—brainstem—brain cancer	0.000512	0.0323	CbGeAlD
Ciclesonide—Rash—Carmustine—brain cancer	0.000507	0.0023	CcSEcCtD
Ciclesonide—Dermatitis—Carmustine—brain cancer	0.000507	0.0023	CcSEcCtD
Ciclesonide—Headache—Carmustine—brain cancer	0.000504	0.00228	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—brain cancer	0.000494	0.00224	CcSEcCtD
Ciclesonide—Rash—Temozolomide—brain cancer	0.00049	0.00222	CcSEcCtD
Ciclesonide—Dermatitis—Temozolomide—brain cancer	0.00049	0.00222	CcSEcCtD
Ciclesonide—Headache—Temozolomide—brain cancer	0.000487	0.00221	CcSEcCtD
Ciclesonide—Nausea—Carmustine—brain cancer	0.000478	0.00217	CcSEcCtD
Ciclesonide—CES1—brain—brain cancer	0.000469	0.0296	CbGeAlD
Ciclesonide—SERPINA6—brain—brain cancer	0.000469	0.0296	CbGeAlD
Ciclesonide—Nausea—Temozolomide—brain cancer	0.000462	0.00209	CcSEcCtD
Ciclesonide—NR3C1—telencephalon—brain cancer	0.000455	0.0287	CbGeAlD
Ciclesonide—Asthenia—Etoposide—brain cancer	0.000446	0.00202	CcSEcCtD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000429	0.0136	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000413	0.0131	CbGpPWpGaD
Ciclesonide—Dizziness—Etoposide—brain cancer	0.000412	0.00186	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000409	0.0129	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000397	0.0126	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000397	0.0126	CbGpPWpGaD
Ciclesonide—Rash—Etoposide—brain cancer	0.000392	0.00178	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—brain cancer	0.000392	0.00178	CcSEcCtD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000392	0.0124	CbGpPWpGaD
Ciclesonide—Headache—Etoposide—brain cancer	0.00039	0.00177	CcSEcCtD
Ciclesonide—CYP2D6—brainstem—brain cancer	0.000381	0.0241	CbGeAlD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—brain cancer	0.00038	0.012	CbGpPWpGaD
Ciclesonide—NR3C1—gonad—brain cancer	0.00038	0.024	CbGeAlD
Ciclesonide—NR3C1—pituitary gland—brain cancer	0.00037	0.0234	CbGeAlD
Ciclesonide—Nausea—Etoposide—brain cancer	0.00037	0.00167	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—brain cancer	0.000362	0.0115	CbGpPWpGaD
Ciclesonide—NR3C1—medulla oblongata—brain cancer	0.000357	0.0226	CbGeAlD
Ciclesonide—CYP2D6—telencephalon—brain cancer	0.000338	0.0214	CbGeAlD
Ciclesonide—NR3C1—midbrain—brain cancer	0.000327	0.0206	CbGeAlD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000323	0.0102	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000322	0.0102	CbGpPWpGaD
Ciclesonide—NR3C1—spinal cord—brain cancer	0.000319	0.0201	CbGeAlD
Ciclesonide—NR3C1—endocrine gland—brain cancer	0.000287	0.0181	CbGeAlD
Ciclesonide—NR3C1—head—brain cancer	0.000283	0.0179	CbGeAlD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00026	0.00822	CbGpPWpGaD
Ciclesonide—NR3C1—central nervous system—brain cancer	0.000258	0.0163	CbGeAlD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000256	0.00811	CbGpPWpGaD
Ciclesonide—NR3C1—cerebellum—brain cancer	0.000253	0.0159	CbGeAlD
Ciclesonide—CES1—E2F transcription factor network—MYC—brain cancer	0.000245	0.00777	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00022	0.00698	CbGpPWpGaD
Ciclesonide—CYP3A4—endocrine gland—brain cancer	0.000217	0.0137	CbGeAlD
Ciclesonide—CYP2D6—endocrine gland—brain cancer	0.000213	0.0135	CbGeAlD
Ciclesonide—CYP2D6—head—brain cancer	0.000211	0.0133	CbGeAlD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00021	0.00666	CbGpPWpGaD
Ciclesonide—NR3C1—brain—brain cancer	0.000205	0.013	CbGeAlD
Ciclesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000196	0.00619	CbGpPWpGaD
Ciclesonide—CYP3A4—central nervous system—brain cancer	0.000195	0.0123	CbGeAlD
Ciclesonide—CYP2D6—central nervous system—brain cancer	0.000192	0.0121	CbGeAlD
Ciclesonide—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000188	0.00596	CbGpPWpGaD
Ciclesonide—CYP2D6—cerebellum—brain cancer	0.000188	0.0119	CbGeAlD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000174	0.0055	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000171	0.00541	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000169	0.00535	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000169	0.00534	CbGpPWpGaD
Ciclesonide—CYP2D6—brain—brain cancer	0.000153	0.00964	CbGeAlD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000149	0.00472	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000131	0.00415	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000129	0.00409	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000128	0.00405	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IRS2—brain cancer	0.000127	0.00402	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000127	0.00401	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000126	0.00399	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000125	0.00395	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000114	0.00361	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00354	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00011	0.00349	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000101	0.0032	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	9e-05	0.00285	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—brain cancer	8.31e-05	0.00263	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CTNNB1—brain cancer	7.61e-05	0.00241	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	7.32e-05	0.00232	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	7.14e-05	0.00226	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	6.76e-05	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—brain cancer	6.63e-05	0.0021	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.58e-05	0.00208	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.79e-05	0.00183	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT1—brain cancer	3.83e-05	0.00121	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ESR2—brain cancer	3.44e-05	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH2—brain cancer	3.25e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2C9—brain cancer	2.92e-05	0.000926	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—brain cancer	2.77e-05	0.000876	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BSG—brain cancer	2.49e-05	0.000787	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—brain cancer	2.25e-05	0.000713	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH1—brain cancer	2.14e-05	0.000677	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2C9—brain cancer	1.91e-05	0.000605	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENO2—brain cancer	1.69e-05	0.000535	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BSG—brain cancer	1.63e-05	0.000515	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH1—brain cancer	1.4e-05	0.000442	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENO2—brain cancer	1.1e-05	0.00035	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—brain cancer	1.08e-05	0.000343	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—brain cancer	7.75e-06	0.000245	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—brain cancer	5.07e-06	0.00016	CbGpPWpGaD
